Registro:

Referencias:

• Bern, C., Kjos, S., Yabsley, M.J., Montgomery, S.P., Trypanosoma cruzi and chagas' disease in the United States (2011) Clin. Microbiol. Rev., 24, pp. 655-681
• Strasen, J., Williams, T., Ertl, G., Zoller, T., Stich, A., Ritter, O., Epidemiology of Chagas disease in Europe: many calculations, little knowledge (2014) Clin. Res. Cardiol. Off. J. Ger. Card. Soc., 103, pp. 1-10
• WHO, Chagas Disease (American Trypanosomiasis) (2016), http://www.who.int/mediacentre/factsheets/fs340/en/, World Health Organization; Morillo, C.A., Marin-Neto, J.A., Avezum, A., Sosa-Estani, S., Rassi, A.J., Rosas, F., Villena, E., Yusuf, S., Randomized trial of benznidazole for chronic chagas' cardiomyopathy (2015) N. Engl. J. Med., 373, pp. 1295-1306
• Bern, C., Chagas' disease (2015) N. Engl. J. Med., 373, pp. 456-466
• Maguire, J.H., Treatment of Chagas' Disease — Time Is Running Out (2015), http://Dx.doi.org/10.1056/NEJMe1510170, (Accessed 22 November 2016) http://www.nejm.org/doi/full/10.1056/NEJMe1510170; Telleria, C.M., Drug repurposing for cancer therapy (2012) J. Cancer Sci. Ther., 4, pp. ix-xi
• Kaiser, M., Mäser, P., Tadoori, L.P., Ioset, J.-R., Brun, R., Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning (2015) PLoS One, 10, p. e0135556
• Chong, C.R., Sullivan, D.J., New uses for old drugs (2007) Nature, 448, pp. 645-646
• Meng, X.-Y., Zhang, H.-X., Mezei, M., Cui, M., Molecular Docking: a powerful approach for structure-based drug discovery (2011) Curr. Comput. Aided Drug Des., 7, pp. 146-157
• Bellera, C.L., Balcazar, D.E., Alberca, L., Labriola, C.A., Talevi, A., Carrillo, C., Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects (2013) J. Chem. Inf. Model, 53, pp. 2402-2408
• Bellera, C.L., Balcazar, D., Alberca, O.E.L., Labriola, C.A., Talevi, A., Carrillo, C., Bellera, C.L., Carrillo, C., Identification of levothyroxine antichagasic activity through computer-aided drug repurposing, identification of levothyroxine antichagasic activity through computer-aided drug repurposing (2014) Sci. World J. Sci. World J., 2014, p. e279618. , 2014
• Bellera, C.L., Balcazar, D.E., Vanrell, M.C., Casassa, A.F., Palestro, P.H., Gavernet, L., Labriola, C.A., Talevi, A., Computer-guided drug repurposing: identification of trypanocidal activity of clofazimine, benidipine and saquinavir (2015) Eur. J. Med. Chem., 93, pp. 338-348
• Sibley, L.D., Invasion and intracellular survival by Protozoan parasites (2011) Immunol. Rev., 240, pp. 72-91
• Buschiazzo, A., Amaya, M.F., Cremona, M.L., Frasch, A.C., Alzari, P.M., The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis (2002) Mol. Cell., 10, pp. 757-768
• Miller, B.R., Roitberg, A.E., Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis) (2013) Future Med. Chem., 5, pp. 1889-1900
• Silva, B.L., Filho, J.D.S., Andrade, P., Carvalho, I., Alves, R.J., Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase (2014) Bioorg. Med. Chem. Lett., 24, pp. 4529-4532
• Neres, J., Brewer, M.L., Ratier, L., Botti, H., Buschiazzo, A., Edwards, P.N., Mortenson, P.N., Douglas, K.T., Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening (2009) Bioorg. Med. Chem. Lett., 19, pp. 589-596
• Baber, J.C., Shirley, W.A., Gao, Y., Feher, M., The use of consensus scoring in ligand-based virtual screening (2006) J. Chem. Inf. Model, 46, pp. 277-288
• Laskowski, R.A., Swindells, M.B., LigPlot+: multiple ligand-protein interaction diagrams for drug discovery (2011) J. Chem. Inf. Model, 51, pp. 2778-2786
• Agustí, R., París, G., Ratier, L., Frasch, A.C.C., de Lederkremer, R.M., Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo (2004) Glycobiology, 14, pp. 659-670
• De Pablos, L.M., Osuna, A., Multigene families in Trypanosoma cruzi and their role in infectivity (2012) Infect. Immun., 80, pp. 2258-2264
• Amin, A., Chitsazan, M., Navid, H., Left ventricular systolic dysfunction in two patients with ankylosing spondylitis: what is the role of corticosteroids? (2016) Eur. J. Rheumatol., 3, pp. 179-181
• Lui, N.L., Thumboo, J., Inman, R., Cardiomyopathy in ankylosing spondylitis (2011) Arthritis Care Res., 63, pp. 564-569
• Irwin, J.J., Sterling, T., Mysinger, M.M., Bolstad, E.S., Coleman, R.G., ZINC: a free tool to discover chemistry for biology (2012) J. Chem. Inf. Model, 52, pp. 1757-1768
• Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J., AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility (2009) J. Comput. Chem., 30, pp. 2785-2791
• Trott, O., Olson, A.J., AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading (2010) J. Comput. Chem., 31, pp. 455-461
• Velec, H.F.G., Gohlke, H., Klebe, G., DrugScore(CSD)-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction (2005) J. Med. Chem., 48, pp. 6296-6303
• Wang, R., Lai, L., Wang, S., Further development and validation of empirical scoring functions for structure-based binding affinity prediction (2002) J. Comput. Aided Mol. Des., 16, pp. 11-26
• Liu, S., Fu, R., Zhou, L.-H., Chen, S.-P., Application of consensus scoring and principal component analysis for virtual screening against β-secretase (BACE-1) (2012) PLoS One, 7
• Development Core Team, R., R: a Language and Environment for Statistical Computing (2016), https://www.R-project.org, R Found. Stat. Comput Vienna Austria https://www.R-project.org/; Sülsen, V.P., Cazorla, S.I., Frank, F.M., Redko, F.C., Anesini, C.A., Coussio, J.D., Malchiodi, E.L., Muschietti, L.V., Trypanocidal and leishmanicidal activities of flavonoids from Argentine medicinal plants (2007) Am. J. Trop. Med. Hyg., 77, pp. 654-659
• Díaz-Chiguer, D.L., Márquez-Navarro, A., Nogueda-Torres, B., de la Luz León-Ávila, G., Pérez-Villanueva, J., Hernández-Campos, A., Castillo, R., Hernández-Luis, F., In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi (2012) Acta Trop., 122, pp. 108-112
• Villalobos-Rocha, J.C., Sánchez-Torres, L., Nogueda-Torres, B., Segura-Cabrera, A., García-Pérez, C.A., Bocanegra-García, V., Palos, I., Rivera, G., Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives (2014) Parasitol. Res., 113, pp. 2027-2035
• Wong-Baeza, C., Nogueda-Torres, B., Serna, M., Meza-Toledo, S., Baeza, I., Wong, C., Trypanocidal effect of the benzyl ester of N-propyl oxamate: a bi-potential prodrug for the treatment of experimental Chagas disease (2015) BMC Pharmacol. Toxicol., 16
• Mendoza-Martínez, C., Correa-Basurto, J., Nieto-Meneses, R., Márquez-Navarro, A., Aguilar-Suárez, R., Montero-Cortes, M.D., Nogueda-Torres, B., Hernández-Luis, F., Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents (2015) Eur. J. Med. Chem., 96, pp. 296-307
• Cuevas-Hernández, R.I., Correa-Basurto, J., Flores-Sandoval, C.A., Padilla-Martínez, I.I., Nogueda-Torres, B., Villa-Tanaca, M.D.L., Tamay-Cach, F., Trujillo-Ferrara, J.G., Fluorine-containing benzothiazole as a novel trypanocidal agent: design, in silico study, synthesis and activity evaluation (2016) Med. Chem. Res., 25, pp. 211-224
• Elizondo-Jimenez, S., Moreno-Herrera, A., Reyes-Olivares, R., Dorantes-Gonzalez, E., Nogueda-Torres, B., de Oliveira, E.A.G., Romeiro, N.C., Rivera, G., Synthesis, biological evaluation and molecular docking of new benzenesulfonylhydrazone as potential anti-trypanosoma cruzi agents (2016) Med. Chem., 13, pp. 149-158
• Brener, Z., Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi (1962) Rev. Inst. Med. Trop. São Paulo, 4, pp. 389-396
• Buschiazzo, A., Frasch, A.C., Campetella, O., Medium scale production and purification to homogeneity of a recombinant trans-sialidase from Trypanosoma cruzi (1996) Cell. Mol. Biol. noisy–gd. Fr., 42, pp. 703-710
• Cano, M.E., Agusti, R., Cagnoni, A.J., Tesoriero, M.F., Kovensky, J., Uhrig, M.L., de Lederkremer, R.M., Synthesis of divalent ligands of β-thio- and β-N-galactopyranosides and related lactosides and their evaluation as substrates and inhibitors of Trypanosoma cruzi trans-sialidase (2014) Beilstein J. Org. Chem., 10, pp. 3073-3086
• Filardi, L.S., Brener, Z., A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents (1984) Mem. Inst. Oswaldo Cruz, 79, pp. 221-225
• Romanha, A.J., de Castro, S.L., Soeiro, M.D.N.C., Lannes-Vieira, J., Ribeiro, I., Talvani, A., Bourdin, B., Andrade, Z.D.A., In vitro and in vivo experimental models for drug screening and development for Chagas disease (2010) Mem. Inst. Oswaldo Cruz, 105, pp. 233-238

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------